Evidence map›Paper›PMID 32945072›Full record

ArticleEMBO reports2020

Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates.

Johan Aarum, Claudia P Cabrera, Tania A Jones, Shiron Rajendran, Rocco Adiutori, Gavin Giovannoni, Michael R Barnes, Andrea Malaspina, Denise Sheer

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Single-molecule diffusivity quantification inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. 1-L Transcription in Prion Diseases.International journal of molecular sciences · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Nondomain biopolymers: Flexible molecular strategies to acquire biological functions.Genes to cells : devoted to molecular & cellular mechanisms · 2023
    Review
  17. Review
  18. Disrupting pathologic phase transitions in neurodegeneration.The Journal of clinical investigation · 2023
    Review
  19. G-quadruplexes rescuing protein folding.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Johan AarumBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.ORCID 0000-0001-9783-0964
Claudia P CabreraBarts and The London NIHR Cardiovascular Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, UK.ORCID 0000-0002-2205-5315
Tania A JonesBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.ORCID 0000-0002-0067-3382
Shiron RajendranBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.ORCID 0000-0001-9481-829X
Rocco AdiutoriBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.
Gavin GiovannoniBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.ORCID 0000-0001-9995-1700
Michael R BarnesBarts and The London NIHR Cardiovascular Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, UK.ORCID 0000-0001-9097-7381
Andrea MalaspinaBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.
Denise SheerBarts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.ORCID 0000-0001-9067-1796
Queen Mary University of London · GB

Funding

Barts Charity 468/2135Legacy from Mr Ivan FennellMotor Neurone Disease Association MALASPINA/APR13/817-791Motor Neurone Disease Association TURNER/OCT15/972-797Motor Neurone Disease Association (MNDA) 817-791Queen Mary InnovationRosetrees Trust M579UK Research and Innovation/Medical Research Council (MRC) MR/M015882/1Wellcome TrustWellcome Trust Value in People Award
6 · The paper itself

Abstract

Most proteins in cell and tissue lysates are soluble. We show here that in lysate from human neurons, more than 1,300 proteins are maintained in a soluble and functional state by association with endogenous RNA, as degradation of RNA invariably leads to protein aggregation. The majority of these proteins lack conventional RNA-binding domains. Using synthetic oligonucleotides, we identify the importance of nucleic acid structure, with single-stranded pyrimidine-rich bulges or loops surrounded by double-stranded regions being particularly efficient in the maintenance of protein solubility. These experiments also identify an apparent one-to-one protein-nucleic acid stoichiometry. Furthermore, we show that protein aggregates isolated from brain tissue from Amyotrophic Lateral Sclerosis patients can be rendered soluble after refolding by both RNA and synthetic oligonucleotides. Together, these findings open new avenues for understanding the mechanism behind protein aggregation and shed light on how certain proteins remain soluble.

Indexed as

Amyotrophic Lateral SclerosisRNADNA-Binding ProteinsHumansNeuronsProtein AggregatesDNA-Binding ProteinsProtein AggregatesRNAmotor neurone diseaseneurodegenerationphase transitionprotein precipitationribonuclease

Identifiers

PMID32945072
PMCPMC7534620
OpenAlexW3087606457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.